Photobiomodulation Can Prevent Medication-Related Osteonecrosis of the Jaw Formation in Tooth Extraction Site of Rat Model

被引:2
作者
Chegini, Leila [1 ]
Bastami, Farshid [2 ]
Mashhadi-Abbas, Fatemeh [3 ]
Chegini, Reihane [4 ]
Hadadi-Ahangarkolaee, Zahra [1 ]
Fekrazad, Reza [5 ,6 ,7 ]
Dehaki, Mehrzad Gholampour [7 ]
机构
[1] AJA Univ Med Sci, Sch Med, Internal Med Dept, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Dent Sci, Dent Res Ctr, Sch Dent,Oral & Maxillofacial Surg Dept, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Dent, Oral & Maxillofacial Pathol Dept, Tehran, Iran
[4] Iran Univ Med Sci, Sch Med, Med Pathol Dept, Tehran, Iran
[5] AJA Univ Med Sci, Radiat Sci Res Ctr, Tehran, Iran
[6] Universal Sci Educ & Res Network USERN, Int Network Photo Med & Photo Dynam Therapy INPMPD, Tehran, Iran
[7] AJA Univ Med Sci, Sch Med, Endocrinol Dept, Tehran 1946883893, Iran
关键词
photobiomodulation; medication-related osteonecrosis of the jaw; MRONJ; zoledronic acid; rat model; wound healing; BISPHOSPHONATE-RELATED OSTEONECROSIS; LEVEL LASER THERAPY; HUMAN GINGIVAL FIBROBLASTS; ZOLEDRONIC ACID; IN-VITRO; SURGICAL-TREATMENT; CANCER-PATIENTS; RISK-FACTORS; OSTEOBLASTS; CELLS;
D O I
10.1089/photob.2023.0135
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: This study aims to explore the preventive potential of photobiomodulation (PBM) in bisphosphonate-related osteonecrosis of the jaw (BRONJ) using a rat model.Methods: An experimental rat model was established, exposing rats to zoledronic acid (ZA), a primary risk factor for BRONJ. An 810 nm diode laser was applied with parameters of 0.33 W/cm2 power density and 10 J/cm2 energy density for 30 sec. PBM was initiated 1 day pre-extraction and continued for 2 weeks. The impact of PBM on wound healing in both soft and hard tissues was evaluated post tooth extraction.Results: ZA exposure hindered wound healing in both soft and hard tissues after tooth extraction. PBM intervention effectively mitigated the adverse effects of ZA, promoting healing processes in both tissue types. This suggests the potential of PBM as a preventive strategy for BRONJ in patients on long-term bisphosphonate treatment. Moreover, PBM exhibited enhanced wound healing in normal rats, indicating its broader applicability beyond BRONJ cases.Conclusions: PBM shows promise in preventing and improving wound healing in BRONJ and normal cases. These findings underscore the significance of optimizing PBM parameters and suggest its potential clinical relevance as a preventive intervention for BRONJ and a promoter of wound healing.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 69 条
[41]   The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes-in vitro study [J].
Pabst, Andreas M. ;
Ziebart, Thomas ;
Koch, Felix P. ;
Taylor, Katherine Y. ;
Al-Nawas, Bilal ;
Walter, Christian .
CLINICAL ORAL INVESTIGATIONS, 2012, 16 (01) :87-93
[42]   Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw? [J].
Park, Jung-Hyun ;
Kim, Jin-Woo ;
Kim, Sun-Jong .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2017, 75 (06) :1176-1184
[43]   Osteonecrosis of the Jaw and the Role of Macrophages [J].
Pazianas, Michael .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (03) :232-240
[44]   Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts [J].
Ravosa, Matthew J. ;
Ning, Jie ;
Liu, Yueying ;
Stack, M. Sharon .
ARCHIVES OF ORAL BIOLOGY, 2011, 56 (05) :491-498
[45]   Application of Fibrin Associated with Photobiomodulation as a Promising Strategy to Improve Regeneration in Tissue Engineering: A Systematic Review [J].
Reis, Carlos Henrique Bertoni ;
Buchaim, Daniela Vieira ;
Ortiz, Adriana de Cassia ;
Fideles, Simone Ortiz Moura ;
Dias, Jefferson Aparecido ;
Miglino, Maria Angelica ;
Teixeira, Daniel de Bortoli ;
Pereira, Eliana de Souza Bastos Mazuqueli ;
da Cunha, Marcelo Rodrigues ;
Buchaim, Rogerio Leone .
POLYMERS, 2022, 14 (15)
[46]   Efficacy and safety of medical ozone (O3) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study [J].
Ripamonti, Carla Ida ;
Cislaghi, Enrico ;
Mariani, Luigi ;
Maniezzo, Massimo .
ORAL ONCOLOGY, 2011, 47 (03) :185-190
[47]   Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study [J].
Ristow, Oliver ;
Ruckschloss, Thomas ;
Mueller, Michael ;
Berger, Moritz ;
Kargus, Steffen ;
Pautke, Christoph ;
Engel, Michael ;
Hoffmann, Jurgen ;
Freudlsperger, Christian .
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2019, 47 (03) :491-499
[48]  
Rugani P., 2013, J Anal Bioanal Tech, V1, P2
[49]   American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw-2014 Update [J].
Ruggiero, Salvatore L. ;
Dodson, Thomas B. ;
Fantasia, John ;
Goodday, Reginald ;
Aghaloo, Tara ;
Mehrotra, Bhoomi ;
O'Ryan, Felice .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2014, 72 (10) :1938-1956
[50]   Bisphosphonates: The first 40 years [J].
Russell, R. Graham G. .
BONE, 2011, 49 (01) :2-19